These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3326402)

  • 1. [Effect of a newly synthesized immunosuppressor on the course of experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Acta Microbiol Bulg; 1987; 21():82-8. PubMed ID: 3326402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cyclophosphamide in experimental pyelonephritis in mice].
    Slavcheva E; Ivanova E; Georgiev D
    Eksp Med Morfol; 1984; 23(4):186-95. PubMed ID: 6396063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arztl Forsch; 1968 Feb; 22(2):69-72. PubMed ID: 4876157
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic therapy of Escherichia coli pyelonephritis produced in mice undergoing chronic diuresis.
    Hubert EG; Kalmanson GM; Guze LB
    Antimicrob Agents Chemother (Bethesda); 1968; 8():507-10. PubMed ID: 4898538
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antibiotic effect of gentamycin in experimental acute Escherichia coli pyelonephritis].
    Ritzerfeld W; Prat V; Konickova L; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):254-8. PubMed ID: 4880994
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Sep; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibacterial activity of nitrooxyquinoline studied in 2 experimental models of pyelonephritis induced by Escherichia coli in rats].
    Hatala M; Hnátek J; Liska M; Konícková L; Uhlír O; Prát V
    Cas Lek Cesk; 1973; 112(23):722-5. PubMed ID: 4577401
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterial effect of two sulfonamide compoundds in acute experimental E. coli-pyelonephritis].
    Konicková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1969 Oct; 19(10):1717-20. PubMed ID: 4902491
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.
    Nicolle LE; Mulvey MR
    Scand J Infect Dis; 2007; 39(8):748-9. PubMed ID: 17654359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attempted therapy of experimental ascending E. coli pyelonephritis by intravesical administration of furadantin].
    Prát V; Konícková L; Hatala M; Urbanová D
    Cas Lek Cesk; 1968; 107(10):299-302. PubMed ID: 4874671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on chloramphenicol sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prat V; Konickova L; Losse H
    Arch Hyg Bakteriol; 1968 Apr; 152(2):181-6. PubMed ID: 4884481
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konicková L
    Arch Hyg Bakteriol; 1969 Jun; 153(3):254-9. PubMed ID: 4908403
    [No Abstract]   [Full Text] [Related]  

  • 13. Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
    Loew H; Ritzerfeld W
    Int J Clin Pharmacol; 1973 Apr; 7(2):234-7. PubMed ID: 4581342
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental pyelonephritis in mice following ascending infection with E. coli. Chronic phase.
    Tanaka N; Une T; Ogawa H
    Acta Pathol Jpn; 1981 Mar; 31(2):189-98. PubMed ID: 7020332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of antibacterial effect of ampicillin on ascending E. coli pyelonephritis in rats].
    Konícková L; Prát V; Hatala M
    Cesk Farm; 1969 Jun; 18(4):206-8. PubMed ID: 4895577
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the bacterilogy and serology of experimental pyelonephritis under the action of chloramphenicol].
    Ritzerfeld W; Prát V; Konícková L; Losse H
    Arch Hyg Bakteriol; 1967 Oct; 151(5):529-37. PubMed ID: 4882586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial effect of nitrofurantoin in acute, ascending E. coli pyelonephritis of rats].
    Konícková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Jun; 18(6):720-2. PubMed ID: 4885094
    [No Abstract]   [Full Text] [Related]  

  • 18. [First experience with a combined chemotherapeutic agent in pyelonephritis].
    Davogg S; Watschinger B
    Wien Klin Wochenschr; 1970 May; 82(18):337-9. PubMed ID: 4930125
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological studies of Polygonum capitatum Buch-Ham. ex D. Don].
    Ren G; Chang F; Lu S; Zhong H; Zhang G
    Zhongguo Zhong Yao Za Zhi; 1995 Feb; 20(2):107-9, 128. PubMed ID: 7779271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistological, histological and bacteriological studies of acute experimental coli-pyelonephritis of the rat treated with sulfisomidine and prednisolone].
    Dutz W; Ernst B; Hagemann I; Jacob M; Rohde E; Ziegler PF
    Acta Biol Med Ger; 1965; 15(4):480-91. PubMed ID: 5335615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.